A Call for Better Screening for Hereditary Renal Cell Carcinoma

More than 20% of patients with non –clear cell RCC had a germline mutation, and half of this group could benefit from direct systemic therapy.

Source: CancerNetwork - July 12, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news